ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 25 filers reported holding ANI PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,718,000 | -35.1% | 7,000,000 | -31.7% | 0.70% | -19.4% |
| Q4 2017 | $11,896,000 | -31.5% | 10,250,000 | -35.9% | 0.86% | -49.5% |
| Q3 2017 | $17,360,000 | +56.2% | 16,000,000 | +52.4% | 1.71% | +18.1% |
| Q2 2017 | $11,117,000 | -34.5% | 10,500,000 | -34.4% | 1.45% | -46.8% |
| Q1 2017 | $16,966,000 | +227.2% | 16,000,000 | +255.6% | 2.72% | +60.4% |
| Q4 2016 | $5,185,000 | – | 4,500,000 | – | 1.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 46,542 | $43,298,000 | 2.53% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $7,370,000 | 0.75% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,500,000 | $1,388,000 | 0.60% |
| Perceptive Advisors | 15,000,000 | $13,846,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,211,000 | $14,296,000 | 0.34% |
| LINDEN ADVISORS LP | 3,500,000 | $3,258,000 | 0.22% |
| Visium Asset Management, LP | 6,500,000 | $6,067,000 | 0.08% |
| ZAZOVE ASSOCIATES LLC | 1,750,000 | $1,625,000 | 0.08% |
| Investors Capital Advisory Services | 326,000 | $300,000 | 0.06% |
| LAZARD ASSET MANAGEMENT LLC | 15,969,000 | $14,771,000 | 0.04% |